speb/financial-data huggingface dataset:
IVF cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
IVF balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1237865.00
IVF balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 77601.00
IVF cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -68489.00
IVF cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 289800.00
IVF balance_sheet (annual, 2022-12-31) — Net Debt: 672509.00
IVF income_statement (annual, 2022-12-31) — Net Income: -10892511.00
IVF income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -10892511.00
IVF income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -10892511.00
IVF income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -10892511.00
IVF income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -10892511.00
IVF cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -10892511.00
IVF income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -10892511.00
IVF cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1943.00
IVF income_statement (annual, 2022-12-31) — Net Interest Income: -59137.00
IVF cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 800000.00
IVF cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 800000.00
IVF income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -59137.00
IVF balance_sheet (annual, 2022-12-31) — Net PPE: 1850853.00
IVF cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -10785.00
IVF cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 800000.00
IVF balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -977612.00
IVF balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1949.00
IVF balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1949.00
IVF income_statement (annual, 2022-12-31) — Normalized EBITDA: -10749430.00
IVF income_statement (annual, 2022-12-31) — Normalized Income: -10889775.23
IVF cash_flow (annual, 2022-12-31) — Operating Cash Flow: -6603319.00
IVF cash_flow (annual, 2022-12-31) — Operating Gains Losses: 200558.00
IVF income_statement (annual, 2022-12-31) — Operating Income: -10626481.00
IVF income_statement (annual, 2022-12-31) — Operating Revenue: 822196.00
IVF balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 422.00
IVF balance_sheet (annual, 2022-12-31) — Other Current Assets: 190201.00
IVF balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 100000.00
IVF income_statement (annual, 2022-12-31) — Other Income Expense: -204021.00
IVF cash_flow (annual, 2022-12-31) — Other Non Cash Items: 172644.00
IVF balance_sheet (annual, 2022-12-31) — Other Properties: 1829702.00
IVF balance_sheet (annual, 2022-12-31) — Payables: 1349038.00
IVF balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1349038.00
IVF balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 946262.00
IVF balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
IVF income_statement (annual, 2022-12-31) — Pretax Income: -10889639.00
IVF cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
IVF balance_sheet (annual, 2022-12-31) — Properties: 0.00
IVF cash_flow (annual, 2022-12-31) — Purchase Of Business: -68489.00
IVF cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1943.00
IVF cash_flow (annual, 2022-12-31) — Purchase Of PPE: -10785.00
IVF balance_sheet (annual, 2022-12-31) — Raw Materials: 68723.00
IVF balance_sheet (annual, 2022-12-31) — Receivables: 77149.00
IVF income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 850770.00
IVF income_statement (annual, 2022-12-31) — Reconciled Depreciation: 77301.00
IVF cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
IVF income_statement (annual, 2022-12-31) — Research And Development: 544043.00
IVF balance_sheet (annual, 2022-12-31) — Retained Earnings: -49783533.00
IVF income_statement (annual, 2022-12-31) — Selling General And Administration: 9976563.00
IVF balance_sheet (annual, 2022-12-31) — Share Issued: 422.00
IVF cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 800000.00
IVF cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
IVF income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
IVF cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2224419.00
IVF balance_sheet (annual, 2022-12-31) — Stockholders Equity: -977612.00
IVF balance_sheet (annual, 2022-12-31) — Tangible Book Value: -977612.00
IVF income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -727.23
IVF income_statement (annual, 2022-12-31) — Tax Provision: 2872.00
IVF income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
IVF balance_sheet (annual, 2022-12-31) — Total Assets: 3709805.00
IVF balance_sheet (annual, 2022-12-31) — Total Capitalization: -977612.00
IVF balance_sheet (annual, 2022-12-31) — Total Debt: 2270292.00
IVF balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -977612.00
IVF income_statement (annual, 2022-12-31) — Total Expenses: 11448677.00
IVF balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4687417.00
IVF balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3088718.00
IVF balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1349412.00
IVF income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -10626481.00
IVF income_statement (annual, 2022-12-31) — Total Unusual Items: -3463.00
IVF income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3463.00
IVF balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 0.00
IVF balance_sheet (annual, 2022-12-31) — Working Capital: -2716918.00
IVF income_statement (annual, 2022-12-31) — Write Off: 0.00
IVF income_statement (annual, 2023-12-31) — +Operating Expense: 7853293.00
IVF income_statement (annual, 2023-12-31) — +Total Revenue: 3020575.00
IVF balance_sheet (annual, 2023-12-31) — Accounts Payable: 2330381.00
IVF balance_sheet (annual, 2023-12-31) — Accounts Receivable: 140550.00
IVF balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -233593.00
IVF balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 52710721.00
IVF cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 89794.00
IVF income_statement (annual, 2023-12-31) — Basic Average Shares: 1730.00
IVF income_statement (annual, 2023-12-31) — Basic EPS: -4644.28
IVF cash_flow (annual, 2023-12-31) — Beginning Cash Position: 90135.00
IVF cash_flow (annual, 2023-12-31) — Capital Expenditure: -444722.00
IVF balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3537773.00
IVF balance_sheet (annual, 2023-12-31) — Capital Stock: 6000020.00
IVF balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 232424.00
IVF balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 232424.00
IVF balance_sheet (annual, 2023-12-31) — Cash Financial: 232424.00
IVF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 7392222.00
IVF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2494879.00
IVF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -4755054.00
IVF cash_flow (annual, 2023-12-31) — Change In Account Payable: 924678.00
IVF cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -102147.00
IVF cash_flow (annual, 2023-12-31) — Change In Interest Payable: 121864.00
IVF cash_flow (annual, 2023-12-31) — Change In Inventory: -905.00
IVF cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
IVF cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -141377.00
IVF cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 286944.00
IVF cash_flow (annual, 2023-12-31) — Change In Payable: 924678.00
IVF cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 822531.00
IVF cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -432093.00
IVF cash_flow (annual, 2023-12-31) — Change In Receivables: -63401.00
IVF cash_flow (annual, 2023-12-31) — Change In Working Capital: 471699.00
IVF cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -63401.00
IVF cash_flow (annual, 2023-12-31) — Changes In Cash: 142289.00
IVF balance_sheet (annual, 2023-12-31) — Common Stock: 20.00
IVF balance_sheet (annual, 2023-12-31) — Common Stock Equity: -5107404.00
IVF cash_flow (annual, 2023-12-31) — Common Stock Issuance: 5701948.00
IVF income_statement (annual, 2023-12-31) — Cost Of Revenue: 1934437.00
IVF balance_sheet (annual, 2023-12-31) — Current Assets: 1259775.00
IVF balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 181574.00
IVF balance_sheet (annual, 2023-12-31) — Current Debt: 1509920.00
IVF balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1691494.00
IVF balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 408769.00
IVF balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 408769.00
IVF balance_sheet (annual, 2023-12-31) — Current Liabilities: 8002895.00
IVF balance_sheet (annual, 2023-12-31) — Current Notes Payable: 880000.00
IVF cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 200894.00
IVF income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 200894.00
IVF cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 200894.00
IVF income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 200894.00
IVF income_statement (annual, 2023-12-31) — Diluted Average Shares: 1730.00
IVF income_statement (annual, 2023-12-31) — Diluted EPS: -4644.28
IVF income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -8034612.00
IVF income_statement (annual, 2023-12-31) — EBIT: -7080917.00
IVF income_statement (annual, 2023-12-31) — EBITDA: -6880023.00
IVF income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -60270.00
IVF cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 60270.00
IVF cash_flow (annual, 2023-12-31) — End Cash Position: 232424.00
IVF cash_flow (annual, 2023-12-31) — Financing Cash Flow: 7392222.00
IVF balance_sheet (annual, 2023-12-31) — Finished Goods: 211028.00
IVF cash_flow (annual, 2023-12-31) — Free Cash Flow: -5199776.00
IVF cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
IVF income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
IVF income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -420.00
IVF balance_sheet (annual, 2023-12-31) — Goodwill: 5878986.00
IVF balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 9972417.00
IVF balance_sheet (annual, 2023-12-31) — Gross PPE: 4419069.00
IVF income_statement (annual, 2023-12-31) — Gross Profit: 1086138.00
IVF cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
IVF income_statement (annual, 2023-12-31) — Interest Expense: 925909.00
IVF income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 925909.00
IVF income_statement (annual, 2023-12-31) — Interest Income: 0.00
IVF income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
IVF cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 9640.00
IVF balance_sheet (annual, 2023-12-31) — Inventory: 264507.00
IVF balance_sheet (annual, 2023-12-31) — Invested Capital: -2343487.00
IVF cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2494879.00
IVF balance_sheet (annual, 2023-12-31) — Investments And Advances: 3088248.00
IVF balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 916248.00
IVF balance_sheet (annual, 2023-12-31) — Investmentsin Subsidiariesat Cost: 2172000.00
IVF cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 5701948.00
IVF cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3160250.00
IVF balance_sheet (annual, 2023-12-31) — Leases: 538151.00
IVF balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3356199.00
IVF balance_sheet (annual, 2023-12-31) — Long Term Debt: 1253997.00
IVF balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4610196.00
IVF cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3160250.00
IVF cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1495402.00
IVF balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 3088248.00
IVF balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 85404.00
IVF cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -2050157.00
IVF cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 5701948.00
IVF balance_sheet (annual, 2023-12-31) — Net Debt: 2531493.00
IVF income_statement (annual, 2023-12-31) — Net Income: -8034612.00
IVF income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -8034612.00
IVF income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8034612.00
IVF income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -8034612.00
IVF income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -8034612.00
IVF cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8034612.00
IVF income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8034612.00
IVF cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
IVF income_statement (annual, 2023-12-31) — Net Interest Income: -925909.00
IVF cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1664848.00
IVF cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1664848.00
IVF income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -925909.00
IVF balance_sheet (annual, 2023-12-31) — Net PPE: 4185476.00
IVF cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -444722.00
IVF cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
IVF cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 100000.00
IVF balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -9079821.00
IVF balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
IVF balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
IVF income_statement (annual, 2023-12-31) — Normalized EBITDA: -6626531.00
IVF income_statement (annual, 2023-12-31) — Normalized Income: -7834353.32
IVF cash_flow (annual, 2023-12-31) — Operating Cash Flow: -4755054.00
IVF cash_flow (annual, 2023-12-31) — Operating Gains Losses: 223548.00
IVF income_statement (annual, 2023-12-31) — Operating Income: -6767155.00
IVF income_statement (annual, 2023-12-31) — Operating Revenue: 3020575.00
IVF balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1730.00
IVF balance_sheet (annual, 2023-12-31) — Other Current Assets: 622294.00
IVF balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 629920.00
IVF balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 350000.00
IVF income_statement (annual, 2023-12-31) — Other Income Expense: -313762.00
IVF balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 4093431.00
IVF cash_flow (annual, 2023-12-31) — Other Non Cash Items: 900128.00
IVF balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 229.00
IVF balance_sheet (annual, 2023-12-31) — Other Payable: 2500000.00
IVF balance_sheet (annual, 2023-12-31) — Other Properties: 3795514.00
IVF income_statement (annual, 2023-12-31) — Other Special Charges: 163278.00
IVF income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
IVF balance_sheet (annual, 2023-12-31) — Payables: 4830381.00
IVF balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4830381.00
IVF balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 722251.00
IVF balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 0.00
IVF balance_sheet (annual, 2023-12-31) — Preferred Stock: 6000000.00
IVF balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 6000000.00
IVF cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
IVF income_statement (annual, 2023-12-31) — Pretax Income: -8006826.00
IVF cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 25426.00
IVF balance_sheet (annual, 2023-12-31) — Properties: 0.00
IVF cash_flow (annual, 2023-12-31) — Purchase Of Business: -2050157.00
IVF cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
IVF cash_flow (annual, 2023-12-31) — Purchase Of PPE: -444722.00
IVF balance_sheet (annual, 2023-12-31) — Raw Materials: 53479.00
IVF balance_sheet (annual, 2023-12-31) — Receivables: 140550.00
IVF income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1934437.00
IVF income_statement (annual, 2023-12-31) — Reconciled Depreciation: 200894.00
IVF cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1495402.00
IVF income_statement (annual, 2023-12-31) — Research And Development: 165945.00
IVF balance_sheet (annual, 2023-12-31) — Retained Earnings: -57818145.00
IVF cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
IVF cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
IVF income_statement (annual, 2023-12-31) — Selling General And Administration: 7486454.00
IVF balance_sheet (annual, 2023-12-31) — Share Issued: 1730.00
IVF cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 100000.00
IVF income_statement (annual, 2023-12-31) — Special Income Charges: -253072.00
IVF cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1393495.00
IVF balance_sheet (annual, 2023-12-31) — Stockholders Equity: 892596.00
IVF balance_sheet (annual, 2023-12-31) — Tangible Book Value: -15079821.00
IVF income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -53233.32
IVF income_statement (annual, 2023-12-31) — Tax Provision: 27786.00
IVF income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
IVF balance_sheet (annual, 2023-12-31) — Total Assets: 18505916.00
IVF balance_sheet (annual, 2023-12-31) — Total Capitalization: 2146593.00
IVF balance_sheet (annual, 2023-12-31) — Total Debt: 6301690.00
IVF balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 892596.00
IVF income_statement (annual, 2023-12-31) — Total Expenses: 9787730.00
IVF balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 17613320.00
IVF balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 17246141.00
IVF balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 9610425.00
IVF income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -6767155.00
IVF income_statement (annual, 2023-12-31) — Total Unusual Items: -253492.00
IVF income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -253492.00
IVF balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 5000000.00
IVF balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
IVF balance_sheet (annual, 2023-12-31) — Working Capital: -6743120.00
IVF income_statement (annual, 2023-12-31) — Write Off: 89794.00
IVF income_statement (quarterly, 2024-09-30) — +Operating Expense: 1745088.00
IVF income_statement (quarterly, 2024-09-30) — +Total Revenue: 1433151.00
IVF balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2655106.00
IVF balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 257051.00
IVF balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -308261.00
IVF balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 55873514.00
IVF cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 204375.00
IVF cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 204375.00
IVF cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
IVF income_statement (quarterly, 2024-09-30) — Basic Average Shares: 2698.00
IVF income_statement (quarterly, 2024-09-30) — Basic EPS: -604.40
IVF cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 942934.00
IVF balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 2343645.00
IVF balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 2483658.00
IVF balance_sheet (quarterly, 2024-09-30) — Capital Stock: 7644295.00
IVF balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 471591.00
IVF balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 471591.00
IVF balance_sheet (quarterly, 2024-09-30) — Cash Financial: 471591.00
IVF cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: 169464.00
IVF cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: 0.00
IVF cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: -640807.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 250559.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Accrued Expense: 19648.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Interest Payable: 26448.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Inventory: 8527.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 10906.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 145657.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Payable: 250559.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: 270207.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: -41447.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Receivables: 159.00
IVF cash_flow (quarterly, 2024-09-30) — Change In Working Capital: 394009.00
IVF cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 159.00
IVF cash_flow (quarterly, 2024-09-30) — Changes In Cash: -471343.00
IVF balance_sheet (quarterly, 2024-09-30) — Common Stock: 391.00
IVF balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: -7667220.00
IVF cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
IVF income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 988465.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Assets: 1957481.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 230729.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Debt: 1717183.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1947912.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 562402.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 562402.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 8655458.00
IVF balance_sheet (quarterly, 2024-09-30) — Current Notes Payable: 880000.00
IVF cash_flow (quarterly, 2024-09-30) — Depreciation: 26120.00
IVF cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 230495.00
IVF income_statement (quarterly, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 230495.00
IVF cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 230495.00
IVF income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 230495.00
IVF income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 2698.00
IVF income_statement (quarterly, 2024-09-30) — Diluted EPS: -604.40
IVF income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — EBIT: -1327774.00
IVF income_statement (quarterly, 2024-09-30) — EBITDA: -1097279.00
IVF income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: -27372.00
IVF cash_flow (quarterly, 2024-09-30) — Earnings Losses From Equity Investments: 27372.00
IVF cash_flow (quarterly, 2024-09-30) — End Cash Position: 471591.00
IVF cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: 169464.00
IVF balance_sheet (quarterly, 2024-09-30) — Finished Goods: 188002.00
IVF cash_flow (quarterly, 2024-09-30) — Free Cash Flow: -640807.00
IVF income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Goodwill: 5878986.00
IVF balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 9359292.00
IVF balance_sheet (quarterly, 2024-09-30) — Gross PPE: 3067151.00
IVF income_statement (quarterly, 2024-09-30) — Gross Profit: 444686.00
IVF income_statement (quarterly, 2024-09-30) — Interest Expense: 273629.00
IVF income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 273629.00
IVF cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 60529.00
IVF balance_sheet (quarterly, 2024-09-30) — Inventory: 241539.00
IVF balance_sheet (quarterly, 2024-09-30) — Invested Capital: -4815619.00
IVF cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 2943826.00
IVF balance_sheet (quarterly, 2024-09-30) — Investmentsin Joint Venturesat Cost: 771826.00
IVF balance_sheet (quarterly, 2024-09-30) — Investmentsin Subsidiariesat Cost: 2172000.00
IVF cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 137500.00
IVF cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 251750.00
IVF balance_sheet (quarterly, 2024-09-30) — Leases: 96817.00
IVF balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2252929.00
IVF balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1134418.00
IVF balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 3387347.00
IVF cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 251750.00
IVF cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -219786.00
IVF balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 2943826.00
IVF balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 89904.00
IVF cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
IVF cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Net Debt: 2380010.00
IVF income_statement (quarterly, 2024-09-30) — Net Income: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
IVF income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -1630662.00
IVF cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: -1630662.00
IVF income_statement (quarterly, 2024-09-30) — Net Interest Income: -273629.00
IVF cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 31964.00
IVF cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 31964.00
IVF income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -273629.00
IVF balance_sheet (quarterly, 2024-09-30) — Net PPE: 2758890.00
IVF cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
IVF cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 137500.00
IVF balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: -9382608.00
IVF income_statement (quarterly, 2024-09-30) — Normalized EBITDA: -1097279.00
IVF income_statement (quarterly, 2024-09-30) — Normalized Income: -1630662.00
IVF cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: -640807.00
IVF cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 27372.00
IVF income_statement (quarterly, 2024-09-30) — Operating Income: -1300402.00
IVF income_statement (quarterly, 2024-09-30) — Operating Revenue: 1433151.00
IVF balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 2712.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 987300.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 837183.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 350000.00
IVF income_statement (quarterly, 2024-09-30) — Other Income Expense: -27372.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 3480306.00
IVF cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 231649.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 5000000.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Payable: 2500000.00
IVF balance_sheet (quarterly, 2024-09-30) — Other Properties: 536785.00
IVF balance_sheet (quarterly, 2024-09-30) — Payables: 5155106.00
IVF balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 5155106.00
IVF balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 640038.00
IVF balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 7643904.00
IVF balance_sheet (quarterly, 2024-09-30) — Preferred Stock Equity: 7643904.00
IVF cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 137500.00
IVF cash_flow (quarterly, 2024-09-30) — Preferred Stock Payments: 0.00
IVF income_statement (quarterly, 2024-09-30) — Pretax Income: -1601403.00
IVF cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
IVF cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
IVF cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Raw Materials: 53537.00
IVF balance_sheet (quarterly, 2024-09-30) — Receivables: 257051.00
IVF income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 988465.00
IVF income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 230495.00
IVF cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: -219786.00
IVF cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
IVF income_statement (quarterly, 2024-09-30) — Research And Development: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -63541125.00
IVF cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
IVF income_statement (quarterly, 2024-09-30) — Selling General And Administration: 1514593.00
IVF balance_sheet (quarterly, 2024-09-30) — Share Issued: 2712.00
IVF income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
IVF cash_flow (quarterly, 2024-09-30) — Stock Based Compensation: 106330.00
IVF balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: -23316.00
IVF balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: -17026512.00
IVF income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
IVF income_statement (quarterly, 2024-09-30) — Tax Provision: 29259.00
IVF income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.21
IVF balance_sheet (quarterly, 2024-09-30) — Total Assets: 17019489.00
IVF balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 1111102.00
IVF balance_sheet (quarterly, 2024-09-30) — Total Debt: 5335259.00
IVF balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: -23316.00
IVF income_statement (quarterly, 2024-09-30) — Total Expenses: 2733553.00
IVF balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 17042805.00
IVF balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 15062008.00
IVF balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 8387347.00
IVF income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -1300402.00
IVF income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
IVF income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
IVF balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 5000000.00
IVF balance_sheet (quarterly, 2024-09-30) — Working Capital: -6697977.00
IVF income_statement (quarterly, 2024-09-30) — Write Off: 0.00
IVF income_statement (annual, 2024-12-31) — +Operating Expense: 8990284.00
IVF income_statement (quarterly, 2024-12-31) — +Operating Expense: 4192691.00
IVF income_statement (annual, 2024-12-31) — +Total Revenue: 6532000.00
IVF income_statement (quarterly, 2024-12-31) — +Total Revenue: 1685966.00
IVF balance_sheet (annual, 2024-12-31) — Accounts Payable: 3113660.00
IVF balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 3113660.00
IVF balance_sheet (annual, 2024-12-31) — Accounts Receivable: 113108.00
IVF balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 113108.00
IVF balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -335695.00
IVF balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -335695.00
IVF balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 49537054.00
IVF balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 49537054.00
IVF balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -61773.00
IVF balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -61773.00
IVF cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
IVF balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 123313.00
IVF balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 123313.00
IVF income_statement (annual, 2024-12-31) — Basic Average Shares: 2579.00
IVF income_statement (quarterly, 2024-12-31) — Basic Average Shares: 3341.00
IVF income_statement (annual, 2024-12-31) — Basic EPS: -3622.80
IVF income_statement (quarterly, 2024-12-31) — Basic EPS: -1084.80
IVF cash_flow (annual, 2024-12-31) — Beginning Cash Position: 232424.00
IVF cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 471591.00
IVF cash_flow (annual, 2024-12-31) — Capital Expenditure: -183703.00
IVF cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -78874.00
IVF balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1576744.00
IVF balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1576744.00
IVF balance_sheet (annual, 2024-12-31) — Capital Stock: 30375037.00
IVF balance_sheet (quarterly, 2024-12-31) — Capital Stock: 30375037.00
IVF balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 619520.00
IVF balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 619520.00
IVF balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 619520.00
IVF balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 619520.00
IVF balance_sheet (annual, 2024-12-31) — Cash Financial: 619520.00
IVF balance_sheet (quarterly, 2024-12-31) — Cash Financial: 619520.00
IVF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3119477.00
IVF cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 494050.00
IVF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 363895.00
IVF cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 393134.00
IVF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -2974400.00
IVF cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -617379.00
IVF cash_flow (annual, 2024-12-31) — Change In Account Payable: 1350675.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Account Payable: 1064681.00
IVF cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 441437.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 428023.00
IVF cash_flow (annual, 2024-12-31) — Change In Interest Payable: 166772.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Interest Payable: 71145.00
IVF cash_flow (annual, 2024-12-31) — Change In Inventory: 44743.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Inventory: 21775.00
IVF cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 4534.00
IVF cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -35904.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 4883.00
IVF cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 356705.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 39957.00
IVF cash_flow (annual, 2024-12-31) — Change In Payable: 1350675.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Payable: 1064681.00
IVF cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1792112.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 1492704.00
IVF cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -163761.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 347165.00
IVF cash_flow (annual, 2024-12-31) — Change In Receivables: 27442.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Receivables: 82170.00
IVF cash_flow (annual, 2024-12-31) — Change In Working Capital: 2025871.00
IVF cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 1993188.00
IVF cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 27442.00
IVF cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 82170.00
IVF cash_flow (annual, 2024-12-31) — Changes In Cash: 508972.00
IVF cash_flow (quarterly, 2024-12-31) — Changes In Cash: 269805.00
IVF balance_sheet (annual, 2024-12-31) — Common Stock: 37.00
IVF balance_sheet (quarterly, 2024-12-31) — Common Stock: 37.00
IVF balance_sheet (annual, 2024-12-31) — Common Stock Equity: -17790642.00
IVF balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -17790642.00
IVF cash_flow (annual, 2024-12-31) — Common Stock Issuance: 165131.00
IVF cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
IVF income_statement (annual, 2024-12-31) — Cost Of Revenue: 3657766.00
IVF income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 957419.00
IVF balance_sheet (annual, 2024-12-31) — Current Assets: 1256558.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Assets: 1256558.00
IVF balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 181132.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 181132.00
IVF balance_sheet (annual, 2024-12-31) — Current Debt: 6053293.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Debt: 6053293.00
IVF balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6234425.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 6234425.00
IVF balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 602359.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 602359.00
IVF balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 602359.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 602359.00
IVF balance_sheet (annual, 2024-12-31) — Current Liabilities: 17868448.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 17868448.00
IVF balance_sheet (annual, 2024-12-31) — Current Notes Payable: 880000.00
IVF balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 880000.00
IVF cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 919603.00
IVF cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 231810.00
IVF income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 919603.00
IVF income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 231810.00
IVF cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 919603.00
IVF cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 231810.00
IVF income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 919603.00
IVF income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 231810.00
IVF income_statement (annual, 2024-12-31) — Diluted Average Shares: 2579.00
IVF income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 3341.00
IVF income_statement (annual, 2024-12-31) — Diluted EPS: -3622.80
IVF income_statement (quarterly, 2024-12-31) — Diluted EPS: -1084.80
IVF income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -9509588.00
IVF income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -3874128.00
IVF income_statement (annual, 2024-12-31) — EBIT: -6564608.00
IVF income_statement (quarterly, 2024-12-31) — EBIT: -3445677.00
IVF income_statement (annual, 2024-12-31) — EBITDA: -5645005.00
IVF income_statement (quarterly, 2024-12-31) — EBITDA: -3213867.00
IVF income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 9045.00
IVF income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 18467.00
IVF cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -9045.00
IVF cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: -18467.00
IVF cash_flow (annual, 2024-12-31) — End Cash Position: 741396.00
IVF cash_flow (quarterly, 2024-12-31) — End Cash Position: 741396.00
IVF cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3119477.00
IVF cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 494050.00
IVF balance_sheet (annual, 2024-12-31) — Finished Goods: 166227.00
IVF balance_sheet (quarterly, 2024-12-31) — Finished Goods: 166227.00
IVF cash_flow (annual, 2024-12-31) — Free Cash Flow: -3158103.00
IVF cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -696253.00
IVF cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 511663.00
IVF income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: -511663.00
IVF income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
IVF balance_sheet (annual, 2024-12-31) — Goodwill: 5878986.00
IVF balance_sheet (quarterly, 2024-12-31) — Goodwill: 5878986.00
IVF balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 9411917.00
IVF balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 9411917.00
IVF balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 174881.00
IVF balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 174881.00
IVF balance_sheet (annual, 2024-12-31) — Gross PPE: 2295999.00
IVF balance_sheet (quarterly, 2024-12-31) — Gross PPE: 2295999.00
IVF income_statement (annual, 2024-12-31) — Gross Profit: 2874234.00
IVF income_statement (quarterly, 2024-12-31) — Gross Profit: 728547.00
IVF income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
IVF cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
IVF income_statement (annual, 2024-12-31) — Interest Expense: 1035143.00
IVF income_statement (quarterly, 2024-12-31) — Interest Expense: 231824.00
IVF income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1035143.00
IVF income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 231824.00
IVF cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 214742.00
IVF cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 45700.00
IVF balance_sheet (annual, 2024-12-31) — Inventory: 219764.00
IVF balance_sheet (quarterly, 2024-12-31) — Inventory: 219764.00
IVF balance_sheet (annual, 2024-12-31) — Invested Capital: -10608636.00
IVF balance_sheet (quarterly, 2024-12-31) — Invested Capital: -10608636.00
IVF cash_flow (annual, 2024-12-31) — Investing Cash Flow: 363895.00
IVF cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 393134.00
IVF balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
IVF balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
IVF balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 740759.00
IVF balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 740759.00
IVF balance_sheet (annual, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
IVF balance_sheet (quarterly, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
IVF cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1809035.00
IVF cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
IVF cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1344250.00
IVF cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 650000.00
IVF balance_sheet (annual, 2024-12-31) — Leases: 96817.00
IVF balance_sheet (quarterly, 2024-12-31) — Leases: 96817.00
IVF balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1395612.00
IVF balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 1395612.00
IVF balance_sheet (annual, 2024-12-31) — Long Term Debt: 1128713.00
IVF balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 1128713.00
IVF balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2524325.00
IVF balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2524325.00
IVF cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1344250.00
IVF cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 650000.00
IVF cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -934419.00
IVF cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -155950.00
IVF balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
IVF balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
IVF balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 89904.00
IVF balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 89904.00
IVF cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 472008.00
IVF cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 472008.00
IVF cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 165131.00
IVF cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
IVF balance_sheet (annual, 2024-12-31) — Net Debt: 6562486.00
IVF balance_sheet (quarterly, 2024-12-31) — Net Debt: 6562486.00
IVF income_statement (annual, 2024-12-31) — Net Income: -9258953.00
IVF income_statement (quarterly, 2024-12-31) — Net Income: -3623493.00
IVF income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -9509588.00
IVF income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -3874128.00
IVF income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -7739953.00
IVF income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -3623493.00
IVF income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -1519000.00
IVF income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -9258953.00
IVF income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3623493.00
IVF income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -7739953.00
IVF income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3623493.00
IVF cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -9258953.00
IVF cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -3623493.00
IVF income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -9258953.00
IVF income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -3623493.00
IVF income_statement (annual, 2024-12-31) — Net Interest Income: -1035143.00
IVF income_statement (quarterly, 2024-12-31) — Net Interest Income: -231824.00
IVF cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 409831.00
IVF cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 494050.00
IVF cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 409831.00
IVF cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 494050.00
IVF income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1035143.00
IVF income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -231824.00
IVF balance_sheet (annual, 2024-12-31) — Net PPE: 1960304.00
IVF balance_sheet (quarterly, 2024-12-31) — Net PPE: 1960304.00
IVF cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -108113.00
IVF cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -78874.00
IVF cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 1643904.00
IVF cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00